New COVID-19 nasal spray therapy aims to 'reduce viral load in the lungs by 100-fold'

“The beauty of this therapy is that it reduces any inflammation that is associated with SARS- CoV-2 in the lungs,” said Dr. Chaturvedi with Gladstone Institutes.
Source: ABC News 6